Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market | Market Research Reports | Market Research Report || Company Profile | Scoop.it

Aarkstore.com announces, a new market research report is available in its vast collection:

Outsourcing in Drug Development: The Contract CRO, Clinical Trial Lab and EDC Market



The cost and time of developing and bringing a drug to market is over $1.3 billion and often takes as long as 15 years, if not longer. Because of this, major pharmaceutical marketers continue to outsource stages of development, and over the years Kalorama Information has observed this process. In past editions of our outsourcing market studies, we found that outsourcing moved from "should" to "must." for manufacturers. This trend has only continued in the past two years.

Contract Research Organizations (CROs) and other entities can expect growing demand for their services. The demand for new drugs remains unabated, but the cost and need to bring those drugs to market is ever-increasing and intensifying. A key cost driver is the large number of failures during the expensive clinical trial phases. Driven by pressures to reduce costs, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry.

Outsourcing in Drug Development: The Contract Research (Clinical Trial) Market is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues.

As part of its comprehensive coverage of this market, this report contains:

A Detailed Introduction to the Clinical Trial Process
Statistics of Drugs in Development by Phase
Market Size and Forecasts for Outsourcing In Drug Development by Academic Medical Center (AMC), Contract Research Organizations and Others.
Main Drivers for Outsourcing in Drug Development
How CROs are Meeting the Challenge of Patient Recruitment
Discussion of Industry and Regulatory Trends Protocols Funded in FY2009 by Percent and Gender
Global R&D Expenditures Outsourced by Percent 2003-2010
Selected Pharmaceutical Company Acquisitions, 2009-2011
Top Ten Therapeutic Categories in R&D
Selected Acquisitions of Leading CROs
Increasing role of EDCs
Globalization Trends in Drug Development and Breakout of Clinical Trials by Region
Directory of Companies
Market Share of Major CROs 2011
Profiles of CROs, Contract Laboratories, Clinical Trial Labs and EDC Solution Companies
As part of Kalorama Information's research process, information for this report is gathered from sources including trade press, company reports and government databases. Kalorama Information's analyst also interviewed dozens of experts in the industry to discover new trends and confirm assumptions.
As part of the report's coverage , the following CROs, clinical trial laboratories, EDC companies and site management networks are profiled:

Charles River Laboratories International, Inc.

Covance, Inc.
Encorium, Inc.
Icon, PLC
Parexel International Corporation
Medical Marketing Services
Pharmaceutical Product Development, Inc
INC Research


Table of Contents :



The Drug Development Process
Government Regulation of Clinical Research
Active Phase I, II & III Clinical Trials
Phase IV Studies: Post Approval
Recruiting for Clinical Trials
The Complexity and Costs Of Clinical Trials Are Increasing
Clinical Trials Worldwide
The Contract Drug Development Industry
R&D Outsourced to Contract Drug Development
Contract Drug Development Market
Trends Affecting Growth of Contract Drug Development Industry
Globalization of Drug Development
Rapid Technological Change Increasing Data
Biotechnology Industry Growth
Increased Regulatory Scrutiny
Need for Fast, Efficient, and Cost-Effective Drug Development
Drug Development Process

More Related Reports :

  Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

  Pharmaceutical Products of the Future: 50-Company Biopharma and Traditional Pipeline Analysis to 2016

  Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics

  Markets for Electrostimulation Devices (Neurostimulation, Cardiac Rhythm Management, Fracture Healing and Others)

  Medical Imaging Markets: Contrast Agents

  The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition

  What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

  World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)

  The World Market for Veterinary Diagnostics

  The Market for Mobile Medical Apps

  Consumer Testing and The Future of DTC Genetic Testing

  The Global Market for Medical Devices, 3rd. Edition

  The World Market for Over The Counter (OTC) Drugs

RSS Link ... http://www.aarkstore.com/feeds/kalorama.xml

For More details about above & other Reports plz contact :



Contact: Marketing team


Email: enquiry@aarkstore.com

URL: http://www.aarkstore.com/



You can also request for sample page of above mention reports on sample@aarkstore.com